国产人妖在线视频I午夜av一区二区三区I国产色一区二区I一级片视频在线观看I一级毛片儿I亚色图I丁香花一区二区I超碰97在线免费I久久精品中文字幕I日韩在线视频观看免费I无码中文字幕色专区I欧美专区亚洲专区I国产tv在线观看I2024最新黄色网址I日本老妇高潮乱hdI成人免费入口I日韩精品视频在线看I国产传媒在线播放I一本岛视频在线观看I自拍日韩亚洲一区在线I国产成人亚洲综合a∨婷婷I国产精品2019I色亚洲天堂Iav黄色免费I欧美大尺度视频

The liver and kidney organ chip system is used to simulate the metabolism and excretion of drugs in the human body to evaluate the toxicity and side effects of drugs on the liver and kidney. The liver-and-kidney organ chip system is an in vitro model that uses microfluidic technology to culture humanized hepatocytes and renal cells in microbioreactors, connected by microfluidic channels, to mimic the physiological environment and function in the human body. Using this system, the metabolites, biomarkers, cellular activity and inflammatory response in the liver and kidney can be monitored in real time, so as to predict the safety and effectiveness of the drug on the human body. Based on the liver-and-kidney organ chip system, the drug toxicity evaluation platform of the anticancer drug cetuximab was evaluated by surface-modified polyethylene glycol. Using the liver and kidney organ chip system to simulate the drug response in different disease states, to evaluate the adaptive and individualized treatment effect of drugs to specific patient populations. Liver and kidney organ chip system can change the cell type, number, proportion, gene expression to simulate different disease models, such as non-alcoholic steatohepatitis, acute kidney injury, multiple myeloma, etc., and observe the drugs in different models of metabolic dynamics, pharmacodynamics and pharmacology characteristics, to provide the basis for the drug individualized treatment. The therapeutic evaluation of cancer cells in serum samples of multiple myeloma patients through surface polyethylene glycol modification through an individualized treatment platform based on liver and kidney organ chip system.